Vericel (VCEL)
(Delayed Data from NSDQ)
$46.05 USD
+0.60 (1.32%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $45.48 -0.57 (-1.24%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum D VGM
Income Statements
Fiscal Year end for Vericel Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 198 | 164 | 156 | 124 | 118 |
Cost Of Goods | 62 | 55 | 50 | 40 | 38 |
Gross Profit | 136 | 110 | 106 | 84 | 80 |
Selling & Adminstrative & Depr. & Amort Expenses | 142 | 127 | 114 | 82 | 92 |
Income After Depreciation & Amortization | -6 | -17 | -8 | 2 | -11 |
Non-Operating Income | 5 | 1 | 0 | 1 | 2 |
Interest Expense | 1 | 0 | 0 | 0 | 0 |
Pretax Income | -2 | -16 | -8 | 3 | -10 |
Income Taxes | 1 | 1 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -3 | -17 | -7 | 3 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -3 | -17 | -7 | 3 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -2 | -13 | -4 | 5 | -10 |
Depreciation & Amortization (Cash Flow) | 4 | 4 | 4 | 3 | 1 |
Income After Depreciation & Amortization | -6 | -17 | -8 | 2 | -11 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 47.59 | 47.13 | 46.47 | 47.28 | 44.18 |
Diluted EPS Before Non-Recurring Items | -0.07 | -0.35 | -0.16 | 0.06 | 0.18 |
Diluted Net EPS (GAAP) | -0.07 | -0.35 | -0.16 | 0.06 | -0.22 |
Fiscal Year end for Vericel Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 65.00 | 45.58 | 45.92 | 41.02 |
Cost Of Goods | NA | 16.49 | 14.97 | 15.98 | 14.50 |
Gross Profit | NA | 48.51 | 30.61 | 29.94 | 26.52 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 35.78 | 35.67 | 35.90 | 34.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.73 | -5.06 | -5.96 | -8.18 |
Non-Operating Income | NA | 1.52 | 1.26 | 1.09 | 0.83 |
Interest Expense | NA | 0.16 | 0.15 | 0.15 | 0.15 |
Pretax Income | NA | 14.09 | -3.95 | -5.02 | -7.50 |
Income Taxes | NA | 1.10 | -0.29 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 12.99 | -3.66 | -5.02 | -7.50 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 12.99 | -3.66 | -5.02 | -7.50 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 50.51 | 47.65 | 47.57 | 47.39 |
Diluted EPS Before Non-Recurring Items | NA | 0.26 | -0.08 | -0.11 | -0.16 |
Diluted Net EPS (GAAP) | NA | 0.28 | -0.08 | -0.11 | -0.16 |